Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer
Nishio, Makoto, Horiike, Atsushi, Murakami, Haruyasu, Yamamoto, Nobuyuki, Kaneda, Hiroyasu, Nakagawa, Kazuhiko, Horinouchi, Hidehito, Nagashima, Masaki, Sekiguchi, Masaru, Tamura, TomohideVolume:
88
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2015.03.010
Date:
June, 2015
File:
PDF, 266 KB
english, 2015